text: Our purpose was to test the impact of single and/or combined treatment with the AT(1)-receptor blocker candesartan and the << HMG-CoA reductase >> inhibitor [[ rosuvastatin ]] on infarct size and neuroscore in transient cerebral ischemia in rats.